As the world is moving from pandemic to endemic, science is helping people to come up with solutions to treat coronavirus. Well, the vaccine is now an old thing, the new game changer to fight the deadly virus is anti-COVID-19 pills that are oral antiviral medicine for the treatment of mild to moderate coronavirus patients. It is said that these antiviral pills will be available soon.
It is reported that there will be two pills to treat coronavirus. One is from Pfizer’s antiviral pill Paxlovid and the other one is Molnupiravir that is manufactured by Merck, Shap and Dohme, and Ridgeback Biotherapeutics.
What are Made-in-India anti-Covid-19 pills Molnupiravir?
The antiviral drug Molnupiravir was earlier developed to treat the flu. Notably, as it is an oral drug, people can take it at home. This drug will be given to patients who have mild to moderate coronavirus symptoms and it is being said that this pill can treat people within four to five days.
How does Molnupiravir work?
This pill works by disrupting the virus’s reproduction. The molecules of Molnupiravir are absorbed by virus-infected cells, where they are converted into a defective version of the building blocks of RNA.
Read Also: Big Stories Today: Muslim man dies inside UP’s Kasganj police station, third non-bailable warrant against former Mumbai Police Commissioner Param Bir Singh, Chennai braces for more rain tomorrow
How effective is this pill?
Professor Sir Munir Pirmohamed, Chair of the Commission on Human Medicines said that this pill is effective in reducing the risk of hospitalisation or death for at-risk non-hospitalised adults with mild-to-moderate COVID-19 by 50 per cent.
Who all can have Molnupiravir?
The MHRA has approved the use of Molnupiravir for patients with mild-to-moderate COVID-19 and at least one risk factor, such as obesity, old age, diabetes or heart disease.